Use of Negative Pressure Wound Therapy in High Risk Surgical Closed Incisions
High Risk Abdominal Wounds
About this trial
This is an interventional treatment trial for High Risk Abdominal Wounds focused on measuring Prevena, faster healing time, surgical site infection
Eligibility Criteria
Inclusion Criteria:
All five of the following criteria must be present for enrollment into the study:
- Signed written informed consent must be provided by the patient or by patient's legally acceptable representative, if patient unable to consent.
- Age > 18 years
- Abdominal operation entering the peritoneal cavity under general anesthesia for colostomy or ileostomy reversal or enterocutaneous fistula excision
- Clean - contaminated OR contaminated OR dirty wound (as defined by Wound Infection Surveillance) OR use of skin flaps for skin closure.
- Complete closure of the surgical wound including the skin.
Exclusion Criteria:
- 1) Known allergic reaction at the wound dressing parts of the Prevena ™ Incision Management System.
(Included but not limited to: sensitivity to silver, allergic or hypersensitivity reaction to acrylic adhesives).
2) Inability to close the abdominal wall at the index procedure. 3) Inability to close the skin at the index procedure. 4) Patients under 18 years old. 5) Pregnant women test
Sites / Locations
- Massachusetts General Hospital
Arms of the Study
Arm 1
Experimental
Negative Pressure Wound Therapy
After the completion of the operation, incisional skin closure was performed using sutures or staples and the wound was then covered with the Negative Pressure Wound therapy Prevena Incision Management System (Kinetic Concepts Inc) as per the manufacturer's instructions of use. Continuous negative pressure was applied at 125 mm Hg. For inpatients, wounds were assessed every 48 hours by inspection and palpation. The dressing was not routinely removed, but the surrounding skin was assessed for cellulitis. The NPWT dressing was removed between post-operative day 5 and 7